Media Advisory - Dr. Chamberland, Expert Spokesperson available to discuss legalization of recreational cannabis
October 15 2018 - 7:00AM
PR Newswire (Canada)
ORLEANS, ON, Oct. 15, 2018 /CNW/ -
Who:
|
Dr. Guy Chamberland,
M.Sc.,
Ph.D.,
|
|
|
|
Interim CEO and Chief
Scientific Officer, Tetra Bio-Pharma
|
Recent live and pre-taped media experience:
- BNN/Bloomberg
- Business of Cannabis
- CJAD
- TVA
Background:
- Tetra Bio-Pharma is a global leader in the discovery and
development of cannabis and cannabinoid drugs.
www.tetrabiopharma.com
- Tetra is the only company in North
America working with Health Canada and the FDA on clinical
trial programs that lead to prescription cannabis drugs.
- Dr. Chamberland has 22 + years of experience in drug
development expertise in regulatory affairs, and the development
and management of clinical research protocols and clinical studies
for botanical medicines.
- He is fluently bilingual and a recognized expert in botanical
medicine, publishing, lecturing and delivering continuing education
workshops on the use of plants in the treatment of such areas as
pain, anxiety, insomnia, and wound healing.
- He is Professor of Botanical Medicine and Principles of
clinical research at the Ecole d'Enseignement Superieur de
Naturopathie du Quebec
(EESNQ).
Topics:
- Is there a way to consume recreational cannabis safely?
- If you have a health condition and plan to use recreational
cannabis – what are the risks?
- Should we expect an increase in ER visits after October 17 and why?
- Should we worry about the lack of scientific evidence to prove
the safety and efficacy of cannabis?
- Will doctors, regulators like Health Canada and bodies like the
Canadian Medical Association ever approve cannabis use?
- How far is Canada/the US away
from having cannabis in pharmacies, and covered by insurance?
An excellent speaker, Dr. Chamberland is available for
media appearances in the Montreal/Southern
Ontario region.
SOURCE Tetra Bio-Pharma
Copyright 2018 Canada NewsWire
Tetra Bio Pharma (TSXV:TBP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Tetra Bio Pharma (TSXV:TBP)
Historical Stock Chart
From Apr 2023 to Apr 2024